Anitocabtagene autoleucel

DB18881InvestigationalCell transplant therapies

Anitocabtagene autoleucel: Overview.

Mechanism: Pharmacologically active on Tumor necrosis factor receptor superfamily member 17
Curator reviewed
Also known as: anito-cel · Anitocabtagene-autoleucel

Resolves to

Compound

Targets

What you can answer from here — as of July 09, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

6Clinical trialsPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Anitocabtagene autoleucel, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.